Status:
UNKNOWN
Ophthalmic Manifestations of Patients With Mucopolysaccharidosis
Lead Sponsor:
Shrouk Shaban Bakr
Conditions:
Ophthalmic Manifestations
Eligibility:
All Genders
Up to 18 years
Brief Summary
Mucopolysaccharidosis (MPSs) are a group of disorders caused by inherited defects in lysosomal enzymes resulting in widespread intra- and extra-cellular accumulation of glycosaminoglycan(1,2). They ha...
Eligibility Criteria
Inclusion
- All patients at any age up to 18 years with any type of MPS confirmed by the enzymatic assay
Exclusion
- Any patient other than MPS
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04770415
Start Date
April 1 2021
End Date
April 1 2023
Last Update
February 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt, 71717